4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0000899243-20-006625
Options or other derivatives
- Exec VP, Comm Optns acquired 379,947 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| BOYER ANDREW S Exec VP, Comm Optns | 2020-02-27 | Grant or award · Restricted Stock Units | +126,649 | 126,649 | D | ||
| BOYER ANDREW S Exec VP, Comm Optns | 2020-02-27 | Grant or award · Performance-Based Restricted Stock Units | +253,298 | 253,298 | D | ||
Loading xslF345X03/doc4.xml…